Omnivium Pharms Drug Patent Portfolio
Omnivium Pharms owns 1 orange book drug protected by 11 US patents Given below is the list of Omnivium Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10016407 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10149843 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10231961 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10413505 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10420760 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10857095 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10894012 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10933060 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10973811 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US11040032 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US9867815 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
Latest Legal Activities on Omnivium Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Omnivium Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 03 Jul, 2024 | US10894012 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 May, 2024 | US10857095 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 08 Mar, 2023 | US10420760 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 Mar, 2023 | US10413505 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Sep, 2022 | US10231961 |
| Surcharge for Late Payment, Large Entity | 13 Jun, 2022 | US10016407 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 13 Jun, 2022 | US10016407 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Jun, 2022 | US10149843 |
|
Maintenance Fee Reminder Mailed
Critical
| 28 Feb, 2022 | US10016407 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Jan, 2022 | US9867815 (Litigated) |
| Surcharge for Late Payment, Large Entity | 14 Jan, 2022 | US9867815 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 06 Sep, 2021 | US9867815 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 22 Jun, 2021 | US11040032 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 22 Jun, 2021 | US11040032 |
|
Email Notification
Critical
| 03 Jun, 2021 | US11040032 |
Omnivium Pharms's Family Patents
Omnivium Pharms drugs have patent protection in a total of 1 countries. It has a significant patent presence in the US with 100.0% of its patents being US patents. Click
below to unlock the full patent family tree.
Omnivium Pharms Drug List
Given below is the complete list of Omnivium Pharms's drugs and the patents protecting them.
1. Numbrino
Numbrino is protected by 11 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10016407 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10149843 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10231961 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10413505 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10420760 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10857095 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10894012 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10933060 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US10973811 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US11040032 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
| US9867815 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Numbrino's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List